semaglutide pill Novo Nordisk's weight-loss wins FDA approval US regulators approve Wegovy pill,
Description
Orexins in the brain-gut axis
In: cgvArticle
43 RobichaudS.OuimetM
the data from individual studies did not reveal any statistically significant differences between GLP-1RAs and placebo
RENAL IMPAIRMENT: No dose adjustment required for renal impairment, but monitor closely in severe renal impairment due to dehydration risk from GI side effects
Baseline electrocardiography may be considered in patients with known arrhythmias or significant cardiac history
